Assistant Professor, Comprehensive Cancer Center, Yale University School of Medicine
Hematology
Dr. Matthew P. Strout, MD
|
|
Give Review
Doctor Matthew P. Strout, MD practices Hematology. He graduated from The Ohio State University College of Medicine. Matthew P. Strout, MD has written publications. He has 31 publications published with PubMed. The lastest publication is: 'Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain rea...' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- A DNA break- and phosphorylation-dependent positive feedback loop promotes immunoglobulin class-switch recombination.
- The role of activation-induced cytidine deaminase in Lymphomagenesis.
- Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human Myeloma.
- Chronic lymphocytic Leukemia: prognostic factors and impact on treatment.
- Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way.
- Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations.
- The MLL partial tandem duplication: evidence for recessive gain-of-function in Acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
- The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell Acute lymphoblastic leukemia.
- Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in Acute myeloid leukemia.
- Core-binding factor (CBF) and MLL-associated primary Acute myeloid leukemia: biology and clinical implications.
- Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed Acute myeloid leukemia; involvement of the WIT-1 gene.
- Detection of minimal residual disease in patients with AML1/ETO-associated Acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain rea...
- Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
- Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts.
- The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in Acute myeloid leukemia.
- Rearrangement of ALL1 (MLL) in Acute myeloid leukemia with normal cytogenetics.
- Adult patients with de novo Acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer ...
- The partial tandem duplication of ALL1 in Acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome.
- Developments in cytogenetics and oncogenes in Acute leukemia.
- Molecular biology of Acute myeloid leukemia.
- The c-kit ligand potentiates the allogeneic mixed lymphocyte reaction.
- Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) Leukemia.
- ML-1 Cell line lacks a germline MLL locus.
- Partial tandem duplication of ALL1 as a recurrent molecular defect in Acute myeloid leukemia with trisomy 11.
- Description of an efficient and highly informative method for the evaluation of hematopoietic chimerism following allogeneic bone marrow transplantation.
- Molecular rearrangement of the ALL-1 gene in Acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.
- ALL-1 tandem duplication in Acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements.
- ALL-1 partial duplication in Acute leukemia.
- Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.
- Ayurvedic herbal medicine and lead poisoning.
Schools
Ohio State University College of Medicine
Yale New Haven Hospital
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Connecticare HMO
- Connecticare POS
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Simplifi
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Education
-
Yale-New Haven Hospital -
The Ohio State University College of Medicine
Hospital
-
Yale-New Haven Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548441157 |
| Last Name Of The Provider | STROUT |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
|
Dr. Scott N. Gettinger, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Demetrios T. Braddock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas P. Duffy, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Bernard G. Forget, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Irwin Nash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian R. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie Halene, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa S. Rome, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence Solomon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raj P. Manchandani, MD |
|
|
Dr. Howard S. Hochster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marie E. Peddinghaus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gina G. Chung, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Karen E. Rabenau, MD |